ArticleBMJ (Clinical research ed.)2011
Effectiveness and cost effectiveness of cardiovascular disease prevention in whole populations: modelling study.
Article in BMJ (Clinical research ed.), 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03201523 (Evaluation of a Socio-ecological Cardiovascular Disease Prevention Intervention for Ultra-Orthodox Jewish Hasidic Women Using a Participatory Approach), which is not on this map. Cited by 79 papers, 12 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Evaluation of a Socio-ecological Cardiovascular Disease Prevention Intervention for Ultra-Orthodox Jewish Hasidic Women Using a Participatory Approach
Who cites it
79 citing papers in PubMed, 12 syntheses or guidelines pooled it, 191 citations in OpenAlex.
- Mindfulness based interventions for blood pressure reduction: systematic and umbrella review of existing meta-analyses.Journal of human hypertension · 2026Pooled it
- A Critical Systematic Review of Modelling Approaches and Methodologies used in Hyperlipidaemia Economic Evaluations.PharmacoEconomics · 2026Pooled it
- Neck circumference as a metabolic health marker among women with polycystic ovary syndrome (PCOS): a systematic review and meta-analysis.International journal of obesity (2005) · 2025Pooled it
- Interventions in the workplace to reduce risk factors for noncommunicable diseases: an umbrella review of systematic reviews of effectiveness.Journal of occupational health · 2024Pooled it
- Modelling health and economic impact of nutrition interventions: a systematic review.European journal of clinical nutrition · 2023Pooled it
- Systematic review of dietary trans-fat reduction interventions.Bulletin of the World Health Organization · 2017Pooled it
- Cost-effectiveness of salt reduction to prevent hypertension and CVD: a systematic review.Public health nutrition · 2017Pooled it
- Systematic review of dietary salt reduction policies: Evidence for an effectiveness hierarchy?PloS one · 2017Pooled it
- A systematic review of economic evaluations of population-based sodium reduction interventions.PloS one · 2017Pooled it
- Variations in patient-reported physical health between cardiac and musculoskeletal diseases: systematic review and meta-analysis of population-based studies.Health and quality of life outcomes · 2015Pooled it
- Health gain by salt reduction in europe: a modelling study.PloS one · 2015Pooled it
- Dietary advice for reducing cardiovascular risk.The Cochrane database of systematic reviews · 2013Pooled it
- A multistate model of health transitions in older people: a secondary analysis of ASPREE clinical trial data.The lancet. Healthy longevity · 2022Trial
- Sodium-Containing Pharmaceutical Products as Contributors to Cardiovascular Risk.Journal of the American Heart Association · 2026Review
- The Economics of Cardiac Rehabilitation in North, Central, and South America: A Narrative Review.The Canadian journal of cardiology · 2025Review
- Cost-effectiveness of a novel AI technology to quantify coronary inflammation and cardiovascular risk in patients undergoing routine coronary computed tomography angiography.European heart journal. Quality of care & clinical outcomes · 2025Article
- Public health economic modelling in evaluations of salt and/or alcohol policies: a systematic scoping review.BMC public health · 2025Article
- [Cardiovascular prevention in Saxony-Anhalt : Necessity and new perspectives].Innere Medizin (Heidelberg, Germany) · 2024Review
- Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection.The Lancet. Global health · 2024Review
- Association of cardiovascular health and educational status in a screening cohort.Central European journal of public health · 2024Article
19 more citing papers are in PubMed but not listed here.
Corrections and comments
- Commented on by
- Commented on by
- Commented on by
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
Abstract
objectiveTo estimate the potential cost effectiveness of a population-wide risk factor reduction programme aimed at preventing cardiovascular disease.
designEconomic modelling analysis.
settingEngland and Wales. Population Entire population. Model Spreadsheet model to quantify the reduction in cardiovascular disease over a decade, assuming the benefits apply consistently for men and women across age and risk groups.
main outcome measuresCardiovascular events avoided, quality adjusted life years gained, and savings in healthcare costs for a given effectiveness; estimates of how much it would be worth spending to achieve a specific outcome.
resultsA programme across the entire population of England and Wales (about 50 million people) that reduced cardiovascular events by just 1% would result in savings to the health service worth at least £30m (€34m; $48m) a year compared with no additional intervention. Reducing mean cholesterol concentrations or blood pressure levels in the population by 5% (as already achieved by similar interventions in some other countries) would result in annual savings worth at least £80m to £100m. Legislation or other measures to reduce dietary salt intake by 3 g/day (current mean intake approximately 8.5 g/day) would prevent approximately 30,000 cardiovascular events, with savings worth at least £40m a year. Legislation to reduce intake of industrial trans fatty acid by approximately 0.5% of total energy content might gain around 570,000 life years and generate NHS savings worth at least £230m a year.
conclusionsAny intervention that achieved even a modest population-wide reduction in any major cardiovascular risk factor would produce a net cost saving to the NHS, as well as improving health. Given the conservative assumptions used in this model, the true benefits would probably be greater.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.